Functional and structural characterization of the SARS-CoV-2 spike N481K mutation
Archives of Virology · 2026-07 · 171 (7)
DOI: 10.1007/s00705-026-06652-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, online erschienen am 04.06.2026. Verfasst von Maria K Smatti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center, QU Health, Qatar University, PO Box 2713, Doha, Qatar. msmatti@qu.edu.qa. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University.
Abstract (Originalsprache)
Background
Selective pressure drives SARS-CoV-2 evolution, with spike RBD substitutions shaping ACE2 binding and antibody escape. N481K RBD mutation emerged early in Qatar (2020) and later re-emerged globally, reaching near-fixation by 2024–2025, yet its functional significance remained unexplored.
Methods
We analyzed the temporal and geographic circulation of N481K across > 17 million SARS-CoV-2 genomes (2020–2025). Structural effects were assessed using modeling, docking, and molecular dynamics. Functional impact was evaluated using VSV pseudovirus neutralization tests with sera from infected individuals (n = 48) and vaccinated cohorts: mRNA (n = 16), Sinopharm (n = 45), and AstraZeneca (n = 28).
Results
N481K was detected in 4.14% (703,777/17,016,111) of global genomes and reached near-fixation (> 90%) in dominant Omicron lineages by 2024, with prevalence rising from 71.5% in early 2024 to 94.4% by week 36 of 2025. Structural analyses showed a 0.706 Å RMSD deviation and higher ACE2 docking affinity (–313 vs. − 308 kcal/mol) compared to the wild-type (WT) RBD. Molecular dynamics confirmed increased stability and lower binding free energy for N481K versus WT (–77.07 ± 0.90 vs. − 43.09 ± 0.98 kcal/mol). Among samples with detectable WT neutralization (n = 89), mean neutralization declined from 69.76% (WT) to 42.47% (N481K) (p < 0.0001), with the largest reductions in AstraZeneca, Sinopharm, and infected cohorts. mRNA recipients retained the highest neutralization [77.5% (WT) vs. 56.0% (N481K)].
Conclusion
N481K enhances ACE2 binding while partially evading antibody neutralization, suggesting viral fitness and persistence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biomedical Research Center, QU Health, Qatar University, PO Box 2713, Doha, Qatar. msmatti@qu.edu.qa.
- Biomedical Research Center, QU Health, Qatar University, PO Box 2713, Doha, Qatar.
- Laboratory of Animal Research Center (LARC), Qatar University, PO Box 2713, Doha, Qatar.
- Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, PO Box 2713, Doha, Qatar.
- WHO Collaborating Center for Research & Capacity Building on Emerging & Re-emerging Zoonotic Diseases, Qatar University, PO Box 2713, Doha, Qatar.
Förderung
- Qatar University
Zitieren
APA
Smatti, M. K., Al-Khatib, H., Suleman, M., Nizar, M., Khalid, H. A., Ismail, R., Nasrallah, G. K., & Yassine, H. M. (2026). Functional and structural characterization of the SARS-CoV-2 spike N481K mutation. Archives of Virology, 171(7). https://doi.org/10.1007/s00705-026-06652-y
Vancouver
Smatti MK, Al-Khatib H, Suleman M, Nizar M, Khalid HA, Ismail R, et al. Functional and structural characterization of the SARS-CoV-2 spike N481K mutation. Archives of Virology. 2026;171(7). doi:10.1007/s00705-026-06652-y
BibTeX
@article{Smatti2026,
author = {Smatti, Maria K and Al-Khatib, Hebah and Suleman, Muhammad and Nizar, Muna and Khalid, Hala Abo and Ismail, Ruaa and Nasrallah, Gheyath K and Yassine, Hadi M},
title = {Functional and structural characterization of the SARS-CoV-2 spike N481K mutation},
journal = {Archives of Virology},
year = {2026},
volume = {171},
number = {7},
doi = {10.1007/s00705-026-06652-y}
}
EUVIMED